| language |
eng
|
| Author |
Inoue Satoshi
Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd
Tsuneto Satoru
Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto
Aruga Etsuko
Department of Palliative Medicine, Teikyo University School of Medicine, Tokyo, Japan
Ogata Takeshi
Clinical Development Department, R&D Division, Daiichi Sankyo Co., Ltd
Uemori Mitsutoshi
Biostatistics & Data Management Department, R&D, Daiichi Sankyo Co., Ltd, Tokyo
|
| Subject | hydromorphone; morphine; cancer pain; opioid switching; conversion ratio; efficacy ratio
|
| Journal Title |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| Volume | 48
|
| Issue | 5
|
| Start Page | 442
|
| End Page | 449
|
| ISSN | 0368-2811
|
| ISSN（Online） | 1465-3621
|
| Published Date | 2018-05
|
| DOI | |
| PubMed ID | |
| Publisher | OXFORD UNIV PRESS
|
| NII Type |
Journal Article
|
| OAI-PMH Set |
Faculty of Medicine
|
| Remark | This work was supported by Daiichi Sankyo Company, which paid for all expenses related to preparation of this report and study implementation.
|
